NewsBenzingaKyverna Therapeutics、第3四半期EPSは(0.68ドル)で予想の(0.69ドル)を上回る Kyverna Therapeutics、第3四半期EPSは(0.68ドル)で予想の(0.69ドル)を上回る Benzinga 2026.11.12 13:35 (GMT+0) Open on Benzinga Other news Freedom Broker Maintains Buy on XPeng, Lowers Price Target to $20 Plug Power Shares Slide Toward 52-Week Low Despite New 280-MW Texas Deal Nvidia Vs. Anthropic: Can the AI IPO Challenge Nvidia’s Dominance Across ETFs? Freedom Broker Maintains Buy on Allot, Lowers Price Target to $12.7 Freedom Broker Maintains Hold on Skydance, Lowers Price Target to $8.5 Freedom Broker Upgrades M-Tron Industries to Buy, Lowers Price Target to $84